Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A A.17: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 5: | Line 5: | ||
A.17 | A.17 | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00075-Pub-ich ++ TAG-00265-Cli-tud ++ TAG-00203-Cli-lin ++ TAG-00201-Cli-eSt | ||
| | |RefModule=6 | ||
| | |RefUnit=6.5.0 | ||
}} | }} | ||
| Line 15: | Line 15: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 6 — Unit 6.5.0 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 32: | Line 35: | ||
| | | | ||
|- | |- | ||
! Tags | ! Tags | ||
| | | [[Glossary:TAG-00075-Pub-ich|Publication]], [[Glossary:TAG-00265-Cli-tud|ClinicalTrials.gov]], [[Glossary:TAG-00203-Cli-lin|Investigation plan]], [[Glossary:TAG-00201-Cli-eSt|Clinical investigation]] | ||
|- | |||
| | |||
|- | |||
| | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | ISO ISO 14155 -
Clinical investigation of medical devices for human subjects 2020 |
| Validity area | ISO |
| Scope(s) | MD |
| Document name | ISO 14155 -
Clinical investigation of medical devices for human subjects |
| Version / Revision | 2020 |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | ISO 14155:2020
Clinical investigation of medical devices for human subjects — Good clinical practice |
| Official source | Official link |
| Restricted access | Yes |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 6 — Unit 6.5.0 |
| Scope | MD |
| Document part | Annex A
A.17 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Publication, ClinicalTrials.gov, Investigation plan, Clinical investigation |
| Comment | Publication policy and trial registration statement in CIP |
Content
A.17 Publication policy […]